{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458637802
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = 
| source = o
| target = T-cell receptor
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 127757-92-0
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}
'''Maslimomab''' is a [[mouse]] [[monoclonal antibody]]<ref>[http://apps.who.int/medicinedocs/index/assoc/h5791e/h5791e.pdf WHO Drug Information]</ref> and an [[immunosuppressive drug]].{{Citation needed|date=September 2009}}

==References==
{{reflist}}

{{immunosuppressants}}
{{Monoclonals for immune system}}

[[Category:Monoclonal antibodies]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}